A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor von Rosenbaum, Evan, Kelly, Ciara, D'Angelo, Sandra P., Dickson, Mark A., Gounder, Mrinal, Keohan, Mary L., Movva, Sujana, Condy, Mercedes, Adamson, Travis, Mcfadyen, Chloe R., Antonescu, Christina R., Hwang, Sinchun, Singer, Sam, Qin, Li‐Xuan, Tap, William D., Chi, Ping

Volltext

A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor von Kelly, Ciara M., Shoushtari, Alexander N., Qin, Li-Xuan, D’Angelo, Sandra P., Dickson, Mark A., Gounder, Mrinal M., Keohan, Mary Louise, Mcfadyen, Chloe, Sjoberg, Ana, Singer, Samuel, DeMatteo, Ronald P., Hwang, Sinchun, Heinemann, M. H., Francis, Jasmine H., Antonescu, Cristina R., Chi, Ping, Tap, William D.

Volltext

A phase Ib study of BGJ398 in combination with imatinib in patients with advanced gastrointestinal stromal tumor (GIST) von Kelly, Ciara Marie, Shoushtari, Alexander Noor, Qin, Li-Xuan, D'Angelo, Sandra P., Dickson, Mark Andrew, Gounder, Mrinal M., Keohan, Mary Louise, Sjoberg, Ana, Mcfadyen, Chloe, Hwang, Sinchun, Heinemann, M.H., Francis, Jasmine, Singer, Samuel, DeMatteo, Ronald P., Antonescu, Cristina R., Chi, Ping, Tap, William D.

Volltext